U.S. Banks Stock News

NYSE:CLVT
NYSE:CLVTProfessional Services

Clarivate (CLVT) Valuation Check After Launch Of Web Of Science Research Intelligence AI Platform

Why Clarivate’s New AI Platform Matters for the Stock Clarivate (CLVT) has launched Web of Science Research Intelligence, an AI-native platform built with research institutions to combine curated data, impact metrics, and workflows across funding, collaboration, and research assessment. For shareholders, this fresh product sits at the heart of Clarivate’s existing research and intellectual property data assets, raising questions about adoption, pricing power, and how it may influence...
NYSE:ADM
NYSE:ADMFood

How Investors Are Reacting To Archer-Daniels-Midland (ADM) Upgraded Earnings Guidance And Stronger Biofuel Margins

In May 2026, Archer-Daniels-Midland reported first-quarter sales of US$20,490 million and net income of US$298 million, modestly above the prior year, raised its full-year adjusted earnings guidance, affirmed a quarterly dividend of US$0.52 per share, and held its annual meeting where all management proposals passed and an environmental reporting proposal was rejected. The earnings beat and guidance increase, underpinned by stronger soybean crush, ethanol and Nutrition margins after U.S...
NYSE:KBH
NYSE:KBHConsumer Durables

Is KB Home (KBH) Using New ENERGY STAR Communities To Recast Its Build‑To‑Order Strategy?

KB Home recently opened several new communities across the U.S., including Stevens Ridge in Marysville, Washington, Sunset Oaks and Madera in Texas, and multiple developments in California and Arizona, offering personalized, ENERGY STAR®-designed homes with prices starting from the mid US$200,000s to the US$590,000s range. These geographically diverse launches, all emphasizing efficiency, health-focused features and extensive buyer personalization, highlight KB Home’s continued push into...
NasdaqGS:OTEX
NasdaqGS:OTEXSoftware

Does Open Text (OTEX) Tighten Its Focus or Shrink Its Ambition With Vertica Sale And Steady Guidance?

In early May 2026, Open Text Corporation reported third-quarter results showing higher revenue of US$1,282.5 million and net income of US$172.65 million year-on-year, affirmed its 2026 earnings guidance for 1% to 2% revenue growth after adjusting for US$30 million of divested sales, completed the sale of its Vertica business, and confirmed a quarterly dividend of US$0.2750 per share payable on June 19, 2026. By exiting the non-core Vertica analytics unit and directing the proceeds toward...
NasdaqGS:ERAS
NasdaqGS:ERASBiotechs

Assessing Erasca (ERAS) Valuation After ERAS-0015 Patent And Trade Secret Dispute

Erasca (ERAS) is under pressure after disclosing that Revolution Medicines accused its lead candidate ERAS-0015 of patent infringement and trade secret misappropriation, prompting multiple securities law investigations and raising fresh questions about the program’s long term prospects. See our latest analysis for Erasca. The latest legal headlines arrive after a sharp 43.79% decline in the 30 day share price return. This follows a strong year to date share price return of 184.96% and a very...
NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

Biogen’s Diranersen Moves To Late-Stage Alzheimer’s Trials And Investor Focus

Biogen (NasdaqGS:BIIB) is advancing its experimental Alzheimer’s drug diranersen into late stage trials after Phase 2 CELIA data. The therapy, an antisense oligonucleotide that targets tau protein, did not meet the study’s primary endpoint but showed strong biomarker changes and signs of cognitive benefit. The decision extends Biogen’s Alzheimer’s efforts beyond amyloid focused treatments and increases attention on its neurology pipeline. For you as an investor, this keeps Biogen in the...
NYSE:MSA
NYSE:MSACommercial Services

Assessing MSA Safety (MSA) Valuation After Recent Share Price Volatility

MSA Safety stock snapshot after recent moves MSA Safety (MSA) has drawn fresh attention after recent price swings, with the stock closing at US$171.24. For investors, the question now is how current valuation aligns with fundamentals. See our latest analysis for MSA Safety. Recent trading has been choppy, with the share price falling 15.2% over the past 90 days but still showing a 5.55% year to date share price return and 8.68% one year total shareholder return. This suggests moderating...
NYSE:GNK
NYSE:GNKShipping

Genco Rejects Diana Tender Offer As Control And Governance Battle Escalates

Genco Shipping & Trading (NYSE:GNK) has rejected an unsolicited tender offer from Diana Shipping Inc. The board voted unanimously against the bid and is urging shareholders not to tender their shares. The rejection comes during an active takeover and proxy contest focused on control, valuation, and governance. For investors watching NYSE:GNK, this board level pushback follows a strong run in the stock, with shares up 33.6% year to date and 82.7% over the past year, closing at $24.63. The...
NYSE:AIT
NYSE:AITTrade Distributors

Does Slower Organic Growth Undermine the Automation and M&A Story at Applied Industrial Technologies (AIT)?

In recent commentary, Applied Industrial Technologies has been flagged for underperformance in its core business, with organic revenue and earnings growth over the past two years trailing industry peers and highlighting a heavier dependence on acquisitions to sustain expansion. This weaker internal growth profile, combined with only modestly projected sales improvement, raises questions about how effectively Applied can balance acquisition-driven growth with the health of its underlying...
NYSE:HTH
NYSE:HTHBanks

A Look At Hilltop Holdings (HTH) Valuation After Mixed Recent Share Price Performance

Hilltop Holdings: Recent Performance Snapshot Hilltop Holdings (HTH) has been trading around its recent close of US$36.29, with the stock down about 2% over the past month and roughly 8% over the past 3 months. Despite this pullback, the stock shows a total return of about 20% over the past year and around 25% over the past 3 years, with year-to-date performance near 7%. See our latest analysis for Hilltop Holdings. Recent share price weakness, with the 90 day share price return down 7.6%,...
NYSE:SWK
NYSE:SWKMachinery

Is Stanley Black & Decker (SWK) Offering Value After Its Recent 11.8% Share Price Move

Wondering whether Stanley Black & Decker stock at around US$75 is giving you value or asking too much? Price is only half the story; the real question is what you are getting for it. Over the last month the share price has risen 11.8%, yet it is still down 1.7% year to date and up 10.2% over the past year, which can leave the stock looking very different depending on your time frame. Recent coverage has focused on how the stock's multi year performance, including a 3 year return of 3.8% and...
NasdaqGS:JBHT
NasdaqGS:JBHTTransportation

Supreme Court Ruling Puts Spotlight On J.B. Hunt Valuation And Momentum

U.S. Supreme Court rules that freight brokers can be held liable for damages in trucking incidents. Ruling is seen as supportive of J.B. Hunt Transport Services' vertically integrated trucking and logistics model. Decision may increase legal and compliance risks for asset light brokers that do not operate their own fleets. J.B. Hunt Transport Services, listed as NasdaqGS:JBHT, sits in a different position from many freight brokers because it combines trucking assets with logistics...
NasdaqGS:HSIC
NasdaqGS:HSICHealthcare

A Look At Henry Schein (HSIC) Valuation After Solid Q1 Update And Reaffirmed Guidance

Henry Schein (HSIC) stock is in focus after first quarter results highlighted steady U.S. dental and technology performance, reaffirmed full year guidance, and an industry report that places clinical execution, not scale, at the center of practice growth. See our latest analysis for Henry Schein. Henry Schein’s recent Q1 update, reaffirmed 2026 outlook and ongoing buybacks have supported sentiment. However, the stock’s 30 day share price return is down 6.07% and its 1 year total shareholder...
NasdaqGM:GUTS
NasdaqGM:GUTSMedical Equipment

Fractyl Health (GUTS) Is Up 14.0% After RJVA-001 Human Trial Nod And Q1 Profitability Shift – Has The Bull Case Changed?

In May 2026, Fractyl Health reported first-quarter 2026 net income of US$9.22 million, reversing a prior-year loss, and secured authorization in the Netherlands to begin a Phase 1/2 first-in-human trial of RJVA-001, its Smart GLP-1 gene therapy candidate for type 2 diabetes. An important detail for investors is that this regulatory clearance makes Fractyl a dual clinical-stage company, advancing both its Revita procedure for post‑GLP‑1 weight maintenance and its Rejuva gene therapy platform...
NasdaqGS:PRGS
NasdaqGS:PRGSSoftware

Progress Software Award Spotlights Agentic RAG And Undervalued AI Potential

Progress Software (NasdaqGS:PRGS) has received a 2026 Artificial Intelligence Excellence Award for its Agentic RAG platform. The award recognizes the platform in the Retrieval Augmented Generation (RAG) category for its role in AI driven data solutions. Agentic RAG focuses on converting unstructured data into governed intelligence for enterprise use. For you as an investor, this award draws attention to how Progress Software is positioning itself around operational AI rather than only...
NYSE:ARDT
NYSE:ARDTHealthcare

How Investors Are Reacting To Ardent Health (ARDT) Fujifilm Synapse Imaging Integration Across Hospitals

In early May 2026, FUJIFILM Healthcare Americas announced a partnership to deploy its Synapse enterprise imaging platform across Ardent Health’s acute care hospitals in six states, integrating radiology and cardiology images within Epic’s electronic health record system. This rollout could materially streamline clinician workflows and enhance diagnostic decision-making, potentially reinforcing Ardent Health’s focus on technology-enabled efficiency across its hospital network. We’ll now...